Loading clinical trials...
Loading clinical trials...
Retrospective Data Analysis of Newly Diagnosed Crohn's Disease Patients in Gastroenterological Surgeries
The purpose of this study is to identify prognostic parameters about efficacy of Mesalazine in recently diagnosed patients with Morbus Crohn by retrospective data collection.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Investigational Site, Ehrenfelsstraße 47
Berlin, Germany
Investigational Site, Möllendorfstraße 111
Berlin, Germany
Investigational Site, Graseggerstraße 105
Cologne, Germany
Investigational Site, Münchner Straße 64
Dachau, Germany
Investigational Site, Karlsbader Straße 7
Dinkelsbühl, Germany
Investigational Site, Heiligengrabstraße 16
Hof, Germany
Investigational Site, Am Tiefen Weg 2
Karlstadt am Main, Germany
Investigational Site, Erdbeerfeld 8
Kiel-Altenholz, Germany
Investigational Site, Hohenfelder Straße 20
Koblenz, Germany
Investigational Site, Funkenburgstraße 19
Leipzig, Germany
Start Date
March 1, 2007
Primary Completion Date
May 1, 2010
Completion Date
July 1, 2010
Last Updated
June 1, 2011
161
ACTUAL participants
Lead Sponsor
Ferring Pharmaceuticals
NCT06226883
NCT07184931
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06918808